招商国证生物医药指数A(161726)资产配置 |
|
|
| 报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
| 2025/12/31 |
7,747,410,000 |
6,066,930 |
8,206,830,000 |
8,159,520,000 |
95% |
| 2025/9/30 |
8,994,890,000 |
6,046,390 |
9,565,320,000 |
9,481,380,000 |
95% |
| 2025/6/30 |
8,701,040,000 |
17,773,800 |
9,221,370,000 |
9,176,990,000 |
95% |
| 2025/3/31 |
9,011,810,000 |
148,076,000 |
9,582,760,000 |
9,532,240,000 |
95% |
| 2024/12/31 |
9,274,060,000 |
209,864,000 |
9,865,260,000 |
9,811,240,000 |
95% |
| 2024/9/30 |
10,499,000,000 |
428,196,000 |
11,292,400,000 |
11,052,900,000 |
95% |
| 2024/6/30 |
8,842,370,000 |
328,781,000 |
9,410,840,000 |
9,355,950,000 |
95% |
| 2024/3/31 |
9,794,220,000 |
227,030,000 |
10,416,600,000 |
10,360,800,000 |
95% |
| 2023/12/31 |
11,898,000,000 |
426,688,000 |
12,617,200,000 |
12,563,200,000 |
95% |
| 2023/9/30 |
12,473,000,000 |
14,549,900 |
13,285,000,000 |
13,139,800,000 |
95% |
| 2023/6/30 |
12,218,600,000 |
13,929,900 |
12,963,600,000 |
12,893,600,000 |
95% |
| 2023/3/31 |
12,450,500,000 |
15,134,500 |
13,237,200,000 |
13,155,200,000 |
95% |
| 2022/12/31 |
13,482,100,000 |
29,366,800 |
14,365,000,000 |
14,228,900,000 |
95% |
| 2022/9/30 |
12,776,200,000 |
14,688,300 |
13,572,800,000 |
13,470,800,000 |
95% |
| 2022/6/30 |
14,467,100,000 |
14,210,800 |
15,501,900,000 |
15,376,300,000 |
94% |
| 2022/3/31 |
14,707,100,000 |
14,371,600 |
15,619,000,000 |
15,527,400,000 |
95% |
| 2021/12/31 |
15,459,000,000 |
47,999,500 |
16,531,000,000 |
16,338,800,000 |
95% |
| 2021/9/30 |
10,974,600,000 |
59,957,400 |
11,740,600,000 |
11,642,700,000 |
94% |
| 2021/6/30 |
11,076,400,000 |
19,904,800 |
12,055,500,000 |
11,660,100,000 |
95% |
| 2021/3/31 |
12,068,400,000 |
1,474,370 |
12,930,400,000 |
12,712,400,000 |
95% |
| 2021/1/15 |
14,228,000,000 |
45,292,800 |
15,334,900,000 |
14,984,300,000 |
95% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
